Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
By addressing and balancing hormonal issues, individuals may find it easier to shed excess pounds and maintain a healthier body composition
[124] conducted a double-blind, practical trial in which participants were randomly assigned to receive exenatide or placebo to measure changes in carotid plaque volume and composition at 9 and 18 months of treatment, and found no difference in mean change in plaque volume in the exenatide group compared with placebo
Additional Monitoring May Be Considered In Research Models Involving: History of pancreatitis Gallbladder disease or gallstones Severe gastrointestinal disorders Significant reflux or delayed gastric emptying Type 1 diabetes History of severe hypoglycemia Kidney impairment or increased dehydration risk Eating disorders or severely restricted caloric intake Pregnancy and breastfeeding research contexts Complex metabolic or endocrine-related conditions Additional Caution May Be Considered With Concurrent Research Compounds Such As: Insulin Glucose-lowering compounds Other GLP-1 receptor agonists Appetite-suppressant or stimulant-based compounds Additional Research Considerations Because Tirzepatide may significantly influence appetite, digestion, glucose regulation, and caloric intake, research protocols commonly emphasize: Adequate hydration Sufficient protein intake Electrolyte balance Gradual administration escalation Responses, tolerability, and research observations may vary significantly depending on individual metabolic sensitivity and concurrent research compounds
[16] It helps to lower blood sugar by helping the pancreas produce more insulin
[PMID: 12491384] PubMed record related to this compound for laboratory literature review
The drugs manufacturer, Eli Lilly, is expected to seek FDA approval soon, which could make the medication available within the next several months
